7Baggers
 published on: 2025-10-02 22:38:57  newser.com Fri, 03 Oct 2025 03:38:57 GMT
 published on: 2025-09-30 04:43:03  newser.com Tue, 30 Sep 2025 09:43:03 GMT
 published on: 2025-09-29 23:36:37  newser.com Tue, 30 Sep 2025 04:36:37 GMT
 published on: 2025-09-29 10:02:38  newser.com Mon, 29 Sep 2025 15:02:38 GMT
 published on: 2025-09-29 06:06:18  newser.com Mon, 29 Sep 2025 11:06:18 GMT
 Published on: 2025-09-29 02:56:35  newser.com Mon, 29 Sep 2025 07:56:35 GMT
 published on: 2025-09-29 00:17:50  newser.com Mon, 29 Sep 2025 05:17:50 GMT
 Published on: 2025-09-28 23:47:09  newser.com Mon, 29 Sep 2025 04:47:09 GMT
 Published on: 2025-09-28 03:06:09  newser.com Sun, 28 Sep 2025 08:06:09 GMT
 published on: 2025-09-26 04:44:40  newser.com Fri, 26 Sep 2025 09:44:40 GMT
 published on: 2025-09-22 08:37:52  newser.com Mon, 22 Sep 2025 13:37:52 GMT
 published on: 2025-09-22 06:18:10  newser.com Mon, 22 Sep 2025 11:18:10 GMT
 cocrystal pharma (cocp) files to offer over 5.7 million shares  GuruFocus Fri, 19 Sep 2025 22:03:30 GMT
 published on: 2025-09-19 15:21:00  newser.com Fri, 19 Sep 2025 20:21:00 GMT
 published on: 2025-09-17 01:52:11  newser.com Wed, 17 Sep 2025 06:52:11 GMT
 published on: 2025-09-16 22:00:22  newser.com Wed, 17 Sep 2025 03:00:22 GMT
 published on: 2025-09-16 13:42:11  newser.com Tue, 16 Sep 2025 18:42:11 GMT
 Cocrystal Pharma closes $4.7 million registered direct offering By Investing.com  Investing.com Australia Tue, 16 Sep 2025 06:26:59 GMT
 published on: 2025-09-15 22:35:46  newser.com Tue, 16 Sep 2025 03:35:46 GMT
 cocrystal pharma raises $4.75m in direct offering  TipRanks Tue, 16 Sep 2025 01:54:36 GMT
 cocrystal pharma, inc. announces closing of up to $13  GlobeNewswire Tue, 16 Sep 2025 00:36:43 GMT
 Cocrystal Pharma, Inc. Announces Closing of Up To $13  GlobeNewswire Mon, 15 Sep 2025 20:30:44 GMT
 Cocrystal Pharma closes $4.7 million registered direct offering  Investing.com Mon, 15 Sep 2025 07:00:00 GMT
 Cocrystal Pharma Raises $4.75M in Direct Offering  TipRanks Mon, 15 Sep 2025 07:00:00 GMT
 published on: 2025-09-14 19:06:00  newser.com Mon, 15 Sep 2025 00:06:00 GMT
 published on: 2025-09-13 11:36:19  newser.com Sat, 13 Sep 2025 16:36:19 GMT
 cocrystal’s norovirus drug cdi-988 advances to phase 1b study  Investing.com India Sat, 13 Sep 2025 03:48:27 GMT
 cocrystal pharma advances cdi-988 to phase 1b study  TipRanks Sat, 13 Sep 2025 02:50:45 GMT
 cocrystal pharma announces stock offering and warrant placement  TipRanks Sat, 13 Sep 2025 02:50:45 GMT
 Cocrystal Pharma’s Significant Breakthrough  timothysykes.com Fri, 12 Sep 2025 21:04:00 GMT
 published on: 2025-09-12 14:40:29  Newser Fri, 12 Sep 2025 19:40:29 GMT
 COCP’s Norovirus Breakthrough: Opportunity or Risk?  timothysykes.com Fri, 12 Sep 2025 13:19:00 GMT
 Cocrystal Pharma’s Momentum: Rise or Fall?  StocksToTrade Fri, 12 Sep 2025 07:00:00 GMT
 Cocrystal Pharma Showcases CDI-988, the First Oral  GlobeNewswire Fri, 12 Sep 2025 07:00:00 GMT
 Cocrystal Pharma, Inc. Announces Up To $13 Million  GlobeNewswire Fri, 12 Sep 2025 07:00:00 GMT
 Cocrystal Pharma raises $4.7 million in registered direct offering  Investing.com Fri, 12 Sep 2025 07:00:00 GMT
 Cocrystal Pharma Advances CDI-988 to Phase 1b Study  TipRanks Fri, 12 Sep 2025 07:00:00 GMT
 Cocrystal Pharma Announces Stock Offering and Warrant Placement  TipRanks Fri, 12 Sep 2025 07:00:00 GMT
 warner bros discovery, cocrystal pharma, prenetics global  TradingView Fri, 12 Sep 2025 07:00:00 GMT
 cocrystal pharma reports direct offering; shares rise  MarketScreener Fri, 12 Sep 2025 07:00:00 GMT
 cocrystal pharma (cocp) announces $4.7m direct offering and warr  GuruFocus Fri, 12 Sep 2025 07:00:00 GMT
 cocrystal’s norovirus drug cdi-988 advances to phase 1b study by investing.com  Investing.com Australia Fri, 12 Sep 2025 07:00:00 GMT
 Cocrystal Pharma’s norovirus antiviral study receives FDA clearance  Clinical Trials Arena Tue, 09 Sep 2025 07:00:00 GMT

Cocrystal Pharma, Inc
(NASDAQ:COCP) 

COCP stock logo

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coro...

Founded: 2006
Full Time Employees: 11
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends